1. Home
  2. MRNA vs FITB Comparison

MRNA vs FITB Comparison

Compare MRNA & FITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • FITB
  • Stock Information
  • Founded
  • MRNA 2010
  • FITB 1858
  • Country
  • MRNA United States
  • FITB United States
  • Employees
  • MRNA N/A
  • FITB N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • FITB Major Banks
  • Sector
  • MRNA Health Care
  • FITB Finance
  • Exchange
  • MRNA Nasdaq
  • FITB Nasdaq
  • Market Cap
  • MRNA 34.6B
  • FITB 29.6B
  • IPO Year
  • MRNA 2018
  • FITB N/A
  • Fundamental
  • Price
  • MRNA $54.82
  • FITB $45.37
  • Analyst Decision
  • MRNA Hold
  • FITB Buy
  • Analyst Count
  • MRNA 16
  • FITB 16
  • Target Price
  • MRNA $95.93
  • FITB $41.84
  • AVG Volume (30 Days)
  • MRNA 5.0M
  • FITB 4.1M
  • Earning Date
  • MRNA 11-07-2024
  • FITB 10-18-2024
  • Dividend Yield
  • MRNA N/A
  • FITB 3.26%
  • EPS Growth
  • MRNA N/A
  • FITB N/A
  • EPS
  • MRNA N/A
  • FITB 3.14
  • Revenue
  • MRNA $5,050,000,000.00
  • FITB $8,125,000,000.00
  • Revenue This Year
  • MRNA N/A
  • FITB N/A
  • Revenue Next Year
  • MRNA $5.29
  • FITB $5.19
  • P/E Ratio
  • MRNA N/A
  • FITB $14.45
  • Revenue Growth
  • MRNA N/A
  • FITB N/A
  • 52 Week Low
  • MRNA $54.82
  • FITB $22.49
  • 52 Week High
  • MRNA $170.47
  • FITB $45.57
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 25.28
  • FITB 72.96
  • Support Level
  • MRNA $55.70
  • FITB $41.84
  • Resistance Level
  • MRNA $59.73
  • FITB $45.57
  • Average True Range (ATR)
  • MRNA 2.17
  • FITB 0.84
  • MACD
  • MRNA 0.29
  • FITB 0.27
  • Stochastic Oscillator
  • MRNA 0.00
  • FITB 95.23

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About FITB Fifth Third Bancorp

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $200 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

Share on Social Networks: